The consequences of antipsychotic medication use for people living with dementia: a systematic review and meta-analysis - Top-Institutions - MDSpire

The consequences of antipsychotic medication use for people living with dementia: a systematic review and meta-analysis

  • By

  • Poe Eindra Thant

  • Alina Zenker

  • Johan Jarl

  • Ulf-Göran Gerdtham

  • Cecilia Lenander

  • Sofie Persson

  • Sanjib Saha

  • May 8, 2026

  • 0 min

Share

Top Institutions in Psychiatry

Brief introduction explaining scope and methodology.

  • #1

    Massachusetts General Hospital
    Massachusetts General Hospital

    Boston, Massachusetts

    Key Differentiators

    • Psychiatry
    • Dementia Care

  • #2

    McLean Hospital
    McLean Hospital

    Belmont, Massachusetts

    Key Differentiators

    • Psychiatry
    • Geriatric Psychiatry

  • #3

    VA Greater Los Angeles
    VA Greater Los Angeles

    Los Angeles, California

    Key Differentiators

    • Psychiatry
    • Dementia Care

  • #4

    Umeå University Hospital
    Umeå University Hospital

    Umeå, Sweden

    Key Differentiators

    • Psychiatry
    • Geriatric Medicine

  • #5

    Long-term care of Old people Via KorEan nursing home network (LOVE) study
    Long-term care of Old people Via KorEan nursing home network (LOVE) study

    Seoul, South Korea

    Key Differentiators

    • Geriatric Psychiatry
    • Long-term Care

Original Source(s)

The consequences of antipsychotic medication use for people living with dementia: a systematic review and meta-analysis

  • by Poe Eindra Thant, Alina Zenker, Johan Jarl, Ulf-Göran Gerdtham, Cecilia Lenander, Sofie Persson, Sanjib Saha

  • May 8, 2026

Related Content

Consequences of Impaired Executive Functions in Chief Executives

Irisin Mitigates Microglial Inflammation Induced by β-Amyloid through the miR-451a/TLR4/NLRP3 Pathway

Targeting the miR-32533/CREB5 axis: a promising immunomodulatory and therapeutic strategy for Alzheimer’s disease